| Structure | Chemical Name | CAS | MF |
|
Hydrocortisone VETRANAL
|
|
|
|
|
5-Hydroxythiabendazole VETRANAL
|
|
|
|
|
5-Hydroxymebendazole-d3 VETRANAL
|
|
|
|
Hydrogen tetrachloroaurate hydrate, 99.999%
|
|
AuCl4H3O
|
|
|
Hydrocortisone 21-acetate VETRANAL
|
|
|
|
2-Hydroxy-4-Methyl-5-iodopyridine
|
|
C6H6INO
|
|
3-Hydroxy-2,4,6,7-tetrahydro-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester
|
|
C11H17N3O3
|
|
|
20-Hydroxyecdysone EIA Antiserum
|
|
|
|
|
15-hydroxy Prostaglandin Dehydrogenase (human recombinant)
|
|
|
|
|
β-Hydroxybutyrate (Ketone Body) Assay Kit
|
|
|
|
|
β-Hydroxybutyrate Assay Buffer
|
|
|
|
Hydroperoxy HPLC Mixture
|
|
HO2*
|
|
|
ω-3 Hydroxy Acid HPLC Mixture
|
|
|
|
|
β-Hydroxybutyrate Enzyme Solution
|
|
|
|
4-hydroxy Nonenal Alkyne
|
1011268-23-7
|
C9H12O2
|
|
Hydrogen Peroxide Assay (urinary) Reagent 2
|
|
H2O2
|
|
Hydrogen Peroxide Assay (urinary) Reagent 1
|
|
H2O2
|
|
|
β-Hydroxybutyrate Standard
|
|
|
|
2-Hydroxy-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione
|
23439-88-5
|
C7H4N2O3
|
|
|
11β-Hydroxysteroid Dehydrogenase (Type 2) Polyclonal Antibody
|
|
|
|
4-hydroxy Nonenal Glutathione-d3
|
|
C29H45D3N6O14S2
|
|
|
8-hydroxy-2-deoxy Guanosine EIA Kit
|
|
|
|
4-hydroxy Nonenal Glutathione (trifluoroacetate salt)
|
|
C31H49F3N6O16S2
|
|
|
8-hydroxy-2-deoxy Guanosine AChE Tracer
|
|
|
|
|
8-hydroxy-2-deoxy Guanosine EIA Monoclonal Antibody
|
|
|
|
2-hydroxyethyl 3-(hydroxymethylphosphinoyl)propionate
|
68334-62-3
|
C6H13O5P
|
|
|
15-hydroxy Prostaglandin Dehydrogenase Polyclonal Antibody
|
|
|
|
7-hydroxycoumarinyl-γ-Linolenate
|
161180-12-7
|
C27H34O4
|
|
|
8-hydroxy-2-deoxy Guanosine EIA Standard
|
|
|
|
[1-(2-Hydroxyethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
|
895155-87-0
|
C18H23NO2
|
|
3-hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium salt)
|
|
C27H54D3N11O20P3S+
|
|
|
β-Hydroxybutyrate Colorimetric Detector
|
|
|
|
20-hydroxy N-Arachidonoyl Taurine
|
|
C22H37NO5S
|
|
25-hydroxy Cholesterol-d6
|
88247-69-2
|
C27H40D6O2
|
|
|
15-hydroxy Prostaglandin Dehydrogenase Western Ready Control
|
|
|
|
|
Hydrogen Peroxide (urinary) Assay Kit
|
|
|
|
|
Hydrogen Peroxide (urinary) Standard
|
|
|
|
|
11β-Hydroxysteroid Dehydrogenase (Type 2) Blocking Peptide
|
|
|
|
|
11β-Hydroxysteroid Dehydrogenase (Type 1) Polyclonal Antibody
|
|
|
|
4-hydroxy Nonenal Mercapturic Acid-d3
|
|
C14H22D3NO5S
|
|
1-[1-(2-Hydroxypropyl)-1H-indol-3-yl]ethanone
|
1290631-56-9
|
C13H15NO2
|
|
|
11β-Hydroxysteroid Dehydrogenase (Type 1) Blocking Peptide
|
|
|
|
6-Hydroxy-5H-pyrrolo[3,4-b]pyrazine-5,7(6H)-dione
|
21715-98-0
|
C6H3N3O3
|
|
Hydroxy Bupropion-d9
|
|
C13H9ClD9NO2
|
|
|
11β-Hydroxysteroid Dehydrogenase
|
9041-46-7
|
|
|
Hydrogen Peroxide Assay (urinary) Catalase
|
|
H2O2
|
|
Hydrogen Peroxide Cell-Based Assay Kit
|
|
H2O2
|
|
|
Hydrochlorothiazide-d2 15N2
|
|
|
|
3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27
|
939986-86-4
|
C12H15N3O
|
|
(4-Hydroxy-piperidin-1-yl)-pyrazin-2-yl-Methanone hydrochloride, 98+% C10H14ClN3O2, MW: 243.69
|
1185309-12-9
|
C10H14ClN3O2
|
|
4-((3-hydroxypiperidin-1-yl)Methyl)-N,N-diMethylbenzenesulfonaMide, 98+% C14H22N2O3S, MW: 298.40
|
1185320-06-2
|
C14H22N2O3S
|
|
3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carbonitrile, 98+% C12H15N3O, MW: 217.27
|
939986-69-3
|
C12H15N3O
|
|
4-(3-hydroxypiperidin-1-yl)-N,N-diMethylbenzenesulfonaMide, 98+% C13H20N2O3S, MW: 284.37
|
1185313-49-8
|
C13H20N2O3S
|
|
(3-Hydroxy-piperidin-1-yl)-pyrazin-2-yl-Methanone hydrochloride, 98+% C10H14ClN3O2, MW: 243.69
|
1185309-06-1
|
C10H14ClN3O2
|
|
3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carboxylic acid Methyl ester hydrochloride, 98+% C13H19ClN2O3, MW: 286.76
|
1185312-53-1
|
C13H19ClN2O3
|
|
1-(4-Hydroxy-piperidin-1-yl)-2-thiophen-3-yl-ethanone, 98+% C11H15NO2S, MW: 225.31
|
916791-31-6
|
C11H15NO2S
|
|
4-((3-(hydroxyMethyl)piperidin-1-yl)Methyl)-N,N-diMethylbenzenesulfonaMide, 98+% C15H24N2O3S, MW: 312.43
|
1185307-93-0
|
C15H24N2O3S
|
|
3-(4-Hydroxy-piperidin-1-yl)-1-phenyl-propan-1-one, 98+% C14H19NO2, MW: 233.31
|
1146080-18-3
|
C14H19NO2
|
|
(3-HydroxyMethyl-piperidin-1-yl)-thiophen-3-yl-Methanone, 98+% C11H15NO2S, MW: 225.31
|
916791-30-5
|
C11H15NO2S
|
|
3-Hydroxy-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carbonitrile, 98+% C11H13N3O, MW: 203.04
|
916791-18-9
|
C11H13N3O
|
|
1-(3-Hydroxy-piperidin-1-yl)-2-thiophen-3-yl-ethanone, 98+% C11H15NO2S, MW: 225.31
|
916791-32-7
|
C11H15NO2S
|
|
4-Hydroxy-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-carbonitrile, 98+% C11H13N3O, MW: 203.04
|
916791-19-0
|
C11H13N3O
|
|
3-Hydroxy-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C11H13N3O, MW: 203.24
|
939986-85-3
|
C11H13N3O
|
|
1-(3-HydroxyMethyl-piperidin-1-yl)-2-thiophen-3-yl-ethanone, 98+% C12H17NO2S, MW: 239.34
|
916791-33-8
|
C12H17NO2S
|
|
4-Hydroxy-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C11H13N3O, MW: 203.24
|
939986-84-2
|
C11H13N3O
|
|
(3-Hydroxy-piperidin-1-yl)-thiophen-3-yl-Methanone, 98+% C10H13NO2S, MW: 211.28
|
916791-29-2
|
C10H13NO2S
|
|
3-(3-HydroxyMethyl-piperidin-1-yl)-1-phenyl-propan-1-one, 98+% C15H21NO2, MW: 247.34
|
1146080-19-4
|
C15H21NO2
|
|
2-[2-(3-HydroxyMethyl-piperidin-1-yl)-benzoiMidazol-1-yl]-nicotinonitrile, 98+% C19H19N5O, MW: 333.39
|
1146080-74-1
|
C19H19N5O
|
|
(3-HydroxyMethyl-piperidin-1-yl)-pyrazin-2-yl-Methanone, 98+% C11H15N3O2, MW: 221.26
|
939985-99-6
|
C11H15N3O2
|
|
(4-Hydroxy-piperidin-1-yl)-thiophen-3-yl-Methanone, 98+% C10H13NO2S, MW: 211.28
|
916791-28-1
|
C10H13NO2S
|
|
4-(3-(hydroxyMethyl)piperidin-1-yl)-N,N-diMethylbenzenesulfonaMide, 98+% C14H22N2O3S, MW: 298.40
|
1185307-41-8
|
C14H22N2O3S
|
|
3-(3-Hydroxy-piperidin-1-yl)-1-phenyl-propan-1-one, 98+% C14H19NO2, MW: 233.31
|
746589-13-9
|
C14H19NO2
|
|
4-((4-hydroxypiperidin-1-yl)Methyl)-N,N-diMethylbenzenesulfonaMide, 98+% C14H22N2O3S, MW: 298.40
|
1185318-35-7
|
C14H22N2O3S
|
|
3-(2-hydroxyethyl)cyclopentanone
|
61478-19-1
|
C7H12O2
|
|
11-Hydroxygelsenicine
|
1195760-68-9
|
C19H22N2O4
|
|
3-hydroxy-1,2-diMethylquinolin-4(1H)-one
|
223752-74-7
|
C11H11NO2
|
|
2-Hydroxydiplopterol
|
1193250-54-2
|
C30H52O2
|
|
3-hydroxy-6-Methoxyquinoxaline-2-carboxylic acid
|
|
C10H8N2O4
|
|
4-HYDROXY-3-METHYLCYCLOHEXANONE
|
89897-04-1
|
C7H12O2
|
|
3-hydroxy-3-phenylpropanal
|
39850-43-6
|
C9H10O2
|
|
2-HYDROXY-2-(OXOLAN-2-YL)ACETIC ACID
|
152998-36-2
|
C6H10O4
|
|
3-hydroxyisoquinoline-6-carboxylic acid
|
1337880-39-3
|
C10H7NO3
|
|
2-[2-(2-HYDROXYETHOXY)ETHYL]-1,2,3,4-TETRAHYDROPHTALAZINE -1,4-DIONE
|
1282808-83-6
|
C12H14N2O4
|
|
3-(7-Hydroxy-2-oxo-2H-chromen-3-ylcarbamoyl)acrylic acid methylester
|
|
C14H11NO6
|
|
3-(2-Hydroxyethyl)-2-[3-((3-(2-hydroxyethyl)-5-methyl-3H-benzothiazol-2-ylidene)-2-methyl)-1-propenyl]-5-methyl-benzothiazolium bromide
|
|
C24H27BrN2O2S2
|
|
4-Hydroxy-benzoic acid 4-(6-acryloyloxy-hexyloxy)phenyl ester
|
161841-14-1
|
C22H24O6
|
|
8-Hydroxy-N,N,N',N',N'',N''-hexamethyl-pyrene-1,3,6-trisulfonamid
|
|
C22H25N3O7S3
|
|
5-HydroxyMethyl-pyrazine-2-carboxylic acid ethyl ester
|
1131605-07-6
|
C8H10N2O3
|
|
1-Hydroxy-6-oxo-1,6-dihydro-pyridine-2-carboxylic acid
|
94781-89-2
|
C6H5NO4
|
|
4-hydroxy-2-sulfanylpyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile
|
948575-58-4
|
C6H3N5OS
|
|
4-hydroxy-2-Methyl-5-nitrobenzaldehyde
|
1246085-72-2
|
C8H7NO4
|
|
7-Hydroxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride
|
66393-01-9
|
C9H12ClNO
|
|
2-HYDROXYMETHYL-PIPERAZINE-2HCl
|
122323-87-9
|
C5H13ClN2O
|
|
2-hydroxy-6-Methoxy-1,4-dihydronaphthalene-1,4-dione
|
6223-31-0
|
C11H8O4
|
|
5-Hydroxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride
|
102879-34-5
|
C9H12ClNO
|
|
5-hydroxy-2-MethanesulfonaMidobenzoic acid
|
1243391-74-3
|
C8H9NO5S
|
|
2-(hydroxyMethyl)pyridin-4-ol
|
860411-74-1
|
C6H7NO2
|
|
4-Hydroxyphthalide
|
13161-32-5
|
C8H6O3
|
|
5-hydroxy-3,3-diMethyl-2,3-dihydro-1H-indol-2-one
|
80711-56-4
|
C10H11NO2
|
|
3-Hydroxy-4-nitropyridine N-oxide
|
19355-03-4
|
C5H4N2O4
|